Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson’s disease models through activating the MEF2-PGC1α and BDNF/CREB pathways

T-006, a new derivative of tetramethylpyrazine, has been recently found to protect against 6-hydroxydopamine (6-OHDA)-induced neuronal damage and clear α-synuclein (α-syn) by enhancing proteasome activity in an α-syn transgenic Parkinson’s disease (PD) model. The effect of T-006 on the 1-methyl-4-ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Haiyun, Cao, Jie, Zha, Ling, Wang, Peile, Liu, Zheng, Guo, Baojian, Zhang, Gaoxiao, Sun, Yewei, Zhang, Zaijun, Wang, Yuqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425444/
https://www.ncbi.nlm.nih.gov/pubmed/32710729
http://dx.doi.org/10.18632/aging.103551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425444/
https://www.ncbi.nlm.nih.gov/pubmed/32710729
http://dx.doi.org/10.18632/aging.103551

Ejemplares similares